<DOC>
	<DOCNO>NCT01322971</DOCNO>
	<brief_summary>Bacterial vaginosis ( BV ) common vaginal infection characterize pathologic shift normal vaginal flora . BV associate number poor reproductive outcome , include infertility , preterm labor premature rupture membrane . If BV disrupt normal embryologic development , treatment BV prior conception may improve implantation rate pregnancy outcomes infertile population . This prospective , randomize , double-blind , placebo-controlled trial infertile woman undergo intrauterine insemination embryo transfer screen BV prior treatment . Those patient screen positive BV randomize treatment arm ( metronidazole 500mg mouth twice daily 7 day ) control arm ( placebo mouth twice daily 7 day ) . The primary outcome , positive pregnancy test rate ( i.e . biochemical pregnancy rate ) , assess . Secondary outcome , clinical pregnancy rate , miscarriage rate , live birth rate also examine .</brief_summary>
	<brief_title>Efficacy Study Preconception Treatment Asymptomatic Bacterial Infection Infertility Population</brief_title>
	<detailed_description>The purpose study determine preconception treatment asymptomatic bacterial vaginosis improve pregnancy outcome ( i.e . biochemical pregnancy rate ) . Study protocol follow : 1 . Patients notify study via face-to-face contact initial clinic visit ( baseline ultrasound visit , menstrual cycle day 2-5 ) , physician referral Stanford website . Patients express interest screen person confirm meet enrollment criterion . The participant ask sign inform consent document brief intake questionnaire administer . 2 . Enrolled patient screen bacterial vaginosis next visit ( typically menstrual cycle day 12 ) , prior transvaginal ultrasound . The screening require speculum insert vagina vaginal smear collect swab posterior fornix . A microscopic slide prepare roll swab surface glass slide . The diagnosis bacterial vaginosis establish clinically use Amsel criterion confirm 3 follow 4 sign : clue cell ; vaginal pH â‰¥4.5 ; fishy odor addition 10 % potassium hydroxide solution wet-mount side ; homogeneous , off-white , discharge . For validation clinical diagnosis , 100 % screen positive slide , 10 % screen negative slide , send Department Pathology Gram staining . 3 . The patient positive screen bacterial vaginosis randomize receive metronidazole 500mg orally twice daily seven day ( treatment arm ) placebo orally twice daily seven day ( control arm ) . Randomization perform use computer-generated code . Those patient whose screen negative also follow outcome , randomization perform . 4 . All randomize patient continue routine monitoring insemination plan treat physician . 5 . If pregnancy confirm least 12 week intrauterine insemination ultrasound evidence fetus heartbeat , information collect regard pregnancy outcome . 6 . Primary secondary outcome follow 2 year date enrollment patient .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Abortion , Spontaneous</mesh_term>
	<mesh_term>Vaginal Diseases</mesh_term>
	<mesh_term>Vaginosis , Bacterial</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Women actively try conceive via intrauterine insemination vitro fertilization Current use oral vaginal antibiotic . History allergy adverse reaction metronidazole . Prior enrollment study ( patient return repeat cycle may reenrolled ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Bacterial Vaginosis</keyword>
	<keyword>Infertility</keyword>
	<keyword>Miscarriage</keyword>
	<keyword>Metronidazole</keyword>
</DOC>